CLINICAL_TRIALS
trial_result
· 2014-01-17
Clinical Trial Update: Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]
Summary
Phase 2 trial results evaluating AZD3199 in chronic obstructive pulmonary disease have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: COPD | Phase 2 | Status: COMPLETED | Results posted: 2014-01-17